Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02510846
Other study ID # K140701
Secondary ID PHRIP140325
Status Completed
Phase N/A
First received July 13, 2015
Last updated February 26, 2018
Start date January 15, 2016
Est. completion date July 27, 2017

Study information

Verified date February 2018
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Profound multiple disabilities also called in French polyhandicap are defined by the combination of a deep mental disability and severe motor deficit with extreme restriction of autonomy. Life in institution for people with profound multiple disabilities induces emotional and educative deficiency and often conducts to behavioral disorders. These behavioral disorders also impact on quality of life and feelings of caregivers. An intensive multimodal educative program proposed to patients with profound multiple disabilities can improve their psychic well-being, reduce chronic pain and improve also quality of life and feelings of caregivers. The intensive multimodal educative program will be compared to the usual practice of educative program.


Description:

People with profound multiples disabilities needs particular follow-up with education, care, communication and socialization.

Our hypothesis is that an intensive multimodal educative program of 5 hours a week during 12 months compared to the usual practice of 1 hour a week conducts to the reduction of behavioral disorders and improves the quality of life and feelings of caregivers.

This study is multicenter, controlled, randomized in two parallel groups and open-labelled comparing usual practice of educative program and intensive educative program during 12 months.

The evolution of predominant behavioral disorder and quality of life and feelings of caregivers is evaluated at inclusion (M0), six months after (M6) and twelve months after (M12).


Recruitment information / eligibility

Status Completed
Enrollment 63
Est. completion date July 27, 2017
Est. primary completion date July 27, 2017
Accepts healthy volunteers No
Gender All
Age group 3 Years to 35 Years
Eligibility Inclusion Criteria:

- Hospitalized patient

- Age between 3 and 35 years old

- Patient with multiple disabilities defined by the following 5 criteria:

1. reached or causal brain injury occurred before 3 years and

2. profound mental disability (IQ lower than 35 or not assessable by psychometric tests when patients are too deficient) and

3. motor disability (para-quadraparesis, hemiparesis, diplegia, ataxia, extrapyramidal motor disorders, neuromuscular disorders) and

4. reduced mobility ( Gross Motor Function Classification System score: GMFCS III à V) and

5. extreme autonomy restriction (FMI Functional Independency lower than 50)

- Patient with at least once per week of the following behavioral disorders:

- Restlessness episodes (refusal of physical or verbal contact expressed by gestures aiming to push off other patients or caregivers and/or shouts when caregivers try to approach).

or

• Unexplained crying: according to the Riccilo S.C, Watterson T [Riccilo 1984] definition: fully or partially closed eyes, facial grim/wince and vocalization with or without tears.

or

- Rumination or

- Bruxism or

- Self-mutilations or

- Heteroagressif behavior (bite, pinch, hit) or

- Gestural stereotypies or

- Rythmic movements or

- Iterative frictions

Exclusion Criteria:

- No agreement of participation to the study by the holders of parental authority / legal guardian.

Study Design


Intervention

Behavioral:
Intensive educative management
5 hours a week

Locations

Country Name City State
France Hôpital La Roche Guyon La Roche Guyon

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary To assess the efficacy at 12 months of intensive multimodalitaire educational care compared to usual educational care of patients with multiple disabilities on behavioral disorders. The average number of predominant behavioral disorder will be evaluated by caregivers filling a form twice a day during 7 days.
The predominant behavioral disorder will be identified by the caregivers after 15 days of observation among the following disorders:
Restlessness episodes
Unexplained crying
Rumination
Bruxism
Self-mutilations
Heteroagressif behavior
Gestural Stereotypies
Rythmic movements (swings)
Iterative friction
At the inclusion and 12 months
Secondary Chronic pain. (EDSS scale) Pain evaluation with the validated EDSS scale At the inclusion, 6 months and 12 months.
Secondary Evolution of frequency of behavior disorders. The behavioral disorders will be evaluated during 7 days with a form filled out twice a day by caregivers. At the inclusion, 6 months and 12 months.
Secondary Consumption of psychotropic treatments. Reduction of the number and/or dose of psychotropic treatments. At the inclusion and 12 months.
Secondary Evaluation of the impact of an intensive educative program for patients on chronic stress consequences on referent caregivers at the inclusion, 6 months and 12 months evaluated by the Maslach Burnout Inventory (MBI). At the inclusion, 6 months and 12 months
Secondary Evaluation of the impact of an intensive educative program for patients on implemented strategy to deal with stress among referent caregivers at the inclusion and 12 months. with the Brief-COPE questionnaire. At the inclusion and 12 months.
Secondary Evaluation of the impact of an intensive educative program for patients on emotional distress of referent caregivers evaluated at the inclusion and 12 months with the Hospital Anxiety and Depression Scale (HADS). At the inclusion and 12 months
Secondary Evaluation of the impact of an intensive educative program for patients on quality of life of referent caregivers evaluated at the inclusion and 12 months with the WOQOL-Bref scale. At the inclusion and 12 months
Secondary Evaluation of the impact an intensive educative program on the duration of behavioural problems by the average difference between the inclusion and at 12 months At the inclusion and 12 months
Secondary Evaluation of the impact an intensive educative program on the disorder most invasive behaviour for the patient by the frequency of disappearance between the inclusion and at 12 months and the most pervasive disorder The most pervasive disorder is defined as the most harmful disorder for the patient and/or its management, according to the care teams responsible for each patient At the inclusion and 12 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04935593 - Strengthening Social, Emotional and Behavioral Resilience N/A
Completed NCT05034198 - Remote Training in Rural Schools N/A
Completed NCT03614026 - Teachers and Parents as Partners During Middle School RCT N/A
Enrolling by invitation NCT05039164 - Evaluation of a Remote Training Strategy N/A
Enrolling by invitation NCT04869657 - Sustainment of Mental Health Supports N/A
Not yet recruiting NCT03817710 - Tics in Childern With Acute Deficit Hyper Activity Syndrom
Recruiting NCT05166694 - Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions N/A
Recruiting NCT05510401 - Evaluation of Safe Use of SECURIDRAP® SELFIA® N/A
Completed NCT03736057 - Genetic Evaluation for Medication Selection (GEMS) Study
Not yet recruiting NCT06232226 - Attention Deficit Hyperactivity Disorder N/A
Recruiting NCT05784818 - Up To Me: Erasing the Stigma of Mental Illness on College Campuses N/A
Terminated NCT03904784 - School Withdrawal in Adolescents
Recruiting NCT04675567 - The Safety-Net Approach N/A
Recruiting NCT06315114 - A Transdiagnostic Mentalization-based Intervention for Parents With Mental Disorders N/A
Completed NCT03799783 - The Use of Dexmedetomidine for EEG Sedation in Children With Behavioural Disorders Phase 2
Completed NCT03116100 - Clinical Situations Leading to the Prescription of Neuroleptics by General Practitioner in the Elderly. Practice Survey
Completed NCT02707367 - Recovery Roadmap Phase II Small Business Innovation Research Grant N/A
Completed NCT03161171 - Parental Coping With Challenging Behavior in Mucopolysaccharidosis Type I-III N/A
Completed NCT00006446 - Preventing Problems in Children's Social Behavior N/A
Recruiting NCT04185896 - Perinatal Mental Health Care in Switzerland